Research Article

Characterization and Evaluation of a Folic Acid Receptor-Targeted Norcantharidin/Tetrandrine Dual-Drug Loaded Delivery System

Figure 16

The effects of different formulations on the P-gp expression in HepG2/Adr cells (0: control group; A1-C1: 8 μg/mL of FA-LP@Tet/MSNs, FA-LP/(MSNs@NCTD), and FA-LP@Tet/(MSNs@ NCTD); A2-C2: 16 μg/mL of FA-LP@Tet/MSNs, FA-LP/(MSNs@NCTD), and FA-LP@Tet/(MSNs@ NCTD)).